Certara (NASDAQ:CERT) Hits New 12-Month Low - Here's Why

Certara, Inc. (NASDAQ:CERT - Get Free Report)'s stock price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $10.29 and last traded at $10.30, with a volume of 142876 shares traded. The stock had previously closed at $10.54.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CERT. JMP Securities reiterated a "market perform" rating on shares of Certara in a research report on Wednesday, July 10th. Robert W. Baird decreased their price target on Certara from $19.00 to $18.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. UBS Group upgraded shares of Certara from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Friday, September 27th. Barclays lowered their price objective on Certara from $16.00 to $14.00 and set an "equal weight" rating on the stock in a research report on Tuesday, October 15th. Finally, KeyCorp reduced their target price on Certara from $23.00 to $20.00 and set an "overweight" rating for the company in a research report on Thursday, July 11th. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $17.08.

Certara Trading Down 4.0 %

The stock has a 50 day moving average of $11.55 and a 200 day moving average of $14.26. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.61 and a quick ratio of 2.61. The firm has a market cap of $1.63 billion, a P/E ratio of -25.77, a PEG ratio of 5.40 and a beta of 1.49.

Certara (NASDAQ:CERT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). The firm had revenue of $93.31 million for the quarter, compared to the consensus estimate of $96.01 million. Certara had a negative net margin of 21.64% and a positive return on equity of 3.03%. Certara's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.10 earnings per share. As a group, equities research analysts predict that Certara, Inc. will post 0.27 EPS for the current year.

Insider Activity

In other Certara news, insider Patrick F. Smith sold 5,409 shares of the business's stock in a transaction on Monday, October 7th. The shares were sold at an average price of $11.03, for a total value of $59,661.27. Following the completion of the sale, the insider now directly owns 50,091 shares of the company's stock, valued at $552,503.73. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction on Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the transaction, the insider now directly owns 99,704 shares of the company's stock, valued at $1,125,658.16. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Patrick F. Smith sold 5,409 shares of the company's stock in a transaction on Monday, October 7th. The shares were sold at an average price of $11.03, for a total transaction of $59,661.27. Following the sale, the insider now owns 50,091 shares of the company's stock, valued at $552,503.73. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.39% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Certara

A number of hedge funds have recently modified their holdings of the company. Wasatch Advisors LP grew its stake in shares of Certara by 23.4% in the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company's stock worth $88,056,000 after purchasing an additional 932,598 shares during the last quarter. Capstone Investment Advisors LLC purchased a new position in shares of Certara during the first quarter valued at approximately $245,000. GSA Capital Partners LLP bought a new position in shares of Certara during the first quarter valued at approximately $571,000. Geneva Capital Management LLC raised its holdings in shares of Certara by 15.1% during the first quarter. Geneva Capital Management LLC now owns 4,404,199 shares of the company's stock valued at $78,747,000 after acquiring an additional 579,349 shares in the last quarter. Finally, Texas Permanent School Fund Corp lifted its stake in Certara by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 93,729 shares of the company's stock worth $1,676,000 after acquiring an additional 1,213 shares during the period. Hedge funds and other institutional investors own 73.96% of the company's stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.